Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Dena L Schanzer"'
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141776 (2015)
Most evaluations of epidemic thresholds for influenza have been limited to internal criteria of the indicator variable. We aimed to initiate discussion on appropriate methods for evaluation and the value of cross-validation in assessing the performan
Externí odkaz:
https://doaj.org/article/f3ed3dc2abfc44ad996a9d000e1702f4
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80481 (2013)
BackgroundPoisson regression modelling has been widely used to estimate the disease burden attributable to influenza, though not without concerns that some of the excess burden could be due to other causes. This study aims to provide annual estimates
Externí odkaz:
https://doaj.org/article/b3e7bbddd5774cf2938e935ccd167e67
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e21471 (2011)
BACKGROUND: As observed during the 2009 pandemic, a novel influenza virus can spread globally before the epidemic peaks locally. As consistencies in the relative timing and direction of spread could form the basis for an early alert system, the objec
Externí odkaz:
https://doaj.org/article/c23f35abf93145b394666402cab18a80
Autor:
Dena L Schanzer, Michael J Garner, Todd F Hatchette, Joanne M Langley, Samina Aziz, Theresa W S Tam
Publikováno v:
PLoS ONE, Vol 4, Iss 8, p e6681 (2009)
BACKGROUND:The weekly proportion of laboratory tests that are positive for influenza is used in public health surveillance systems to identify periods of influenza activity. We aimed to estimate the sensitivity of influenza testing in Canada based on
Externí odkaz:
https://doaj.org/article/17f65491b9734d398168b3b1cf7e2fc7
Publikováno v:
Vaccine. 36:7568-7573
Objective The acellular pertussis vaccine was introduced into the routine childhood immunization schedule across Canada in 1997–98 and adolescent booster doses were added between 1999 and 2005. We sought to assess the impact of these changes on inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acac23f0883bb0c99c41d518e17d25da
https://doi.org/10.1016/j.vaccine.2018.10.047
https://doi.org/10.1016/j.vaccine.2018.10.047
Autor:
K Tomas, Lisa Pogany, Margaret Gale-Rowe, Jordan J. Feld, Dena L. Schanzer, N Z Janjua, J Aho, J C Kwong
Publikováno v:
Canada Communicable Disease Report. 44:150-156
BACKGROUNDS: Hospitalizations associated with hepatitis C virus (HCV) infection and liver disease increased on average by 6.0% per year from 2004 to 2010 in Canada and were projected (in 2010) to increase by another 4% by 2016. The first generation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f75314f9c4cbb405c37d045f355161
https://doi.org/10.14745/ccdr.v44i78a01
https://doi.org/10.14745/ccdr.v44i78a01
Autor:
J Aho, Jordan J. Feld, N Z Janjua, Margaret Gale-Rowe, K Tomas, J C Kwong, Dena L. Schanzer, Lisa Pogany
Publikováno v:
Relevé des maladies transmissibles au Canada. 44:167-174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb3cab1b298b868ef6310e346c0ee9b9
https://doi.org/10.14745/ccdr.v44i78a01f
https://doi.org/10.14745/ccdr.v44i78a01f
Autor:
Jordan J. Feld, Dena L. Schanzer, Mawuena Binka, Jason Grebely, Naglaa H. Shoukry, Chris Estes, Jeffrey C. Kwong, Naveed Z. Janjua, Mel Krajden, Jisoo A. Kwon, Homie Razavi
Publikováno v:
JAMA Network Open
Key Points Question What strategies are needed to meet the goal of hepatitis C virus elimination in Canada by 2030? Findings In this decision analytical model, the sustained annual treatment of 10 200 individuals with hepatitis C virus infection was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cdd4f923c04737dcf12b124c57843b7
https://doi.org/10.1001/jamanetworkopen.2020.4192
https://doi.org/10.1001/jamanetworkopen.2020.4192
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195031 (2018)
PLoS ONE
PLoS ONE
BACKGROUND While combination antiretroviral therapy (cART) has significantly improved survival times for persons diagnosed with HIV, estimation of life expectancy (LE) for this cohort remains a challenge, as mortality rates are a function of both tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2fd5a533b5448134ca3420f1af6ca1d
http://europepmc.org/articles/PMC5886421?pdf=render
http://europepmc.org/articles/PMC5886421?pdf=render
Publikováno v:
Influenza and Other Respiratory Viruses
Background A regression-based study design has commonly been used to estimate the influenza burden; however, these estimates are not timely and many countries lack sufficient virological data. Alternative approaches that would permit a timelier asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb8385f70dcf6cb45db84d74679415ac
https://pubmed.ncbi.nlm.nih.gov/29243369
https://pubmed.ncbi.nlm.nih.gov/29243369